NexgenRx, Inc. (NXG.V)
NexgenRx Market Cap : 23.47M for Feb. 11, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cronos Group, Inc. | 1.363B |
| Cannara Biotech, Inc. | 178.15M |
| Medexus Pharmaceuticals, Inc. | 91.10M |
| Arch Biopartners, Inc. | 62.25M |
| Biocure Technology, Inc. | 0.8083M |
Market Cap Related Metrics
| PE Ratio | 21.71 |
| PS Ratio | 1.488 |
| PEG Ratio | 0.0329 |
| Price to Book Value | 3.535 |
| Price | 0.33 |
| Earnings Yield | 4.61% |
| PEGY Ratio | 0.0327 |
| Operating PE Ratio | 26.94 |
| Normalized PE Ratio | 21.57 |